The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...
The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...
Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...
Stacker compiled a list of counties with the highest rates of sexually transmitted infections in Missouri using data from the ...
The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects ...
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...
The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...
President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...
HealthDay News — Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea ... infections to curb the spread of infection, there remains substantial ...